to plastic. All progenitor cell assays were performed by the plasma clot method. Sera, plasmas, conditioned media, and Epo were stored before the initiation of the study in quantities sufficient to complete all assays. CFU-E and BFU-E were plated at concentrations of 2 x i0 cells/mL in medium containing 30% heat-inactivated human AB serum and 1 or 3 U/mL of rHuEpo, respectively.
In another set of cultures, 1% (vol/vol) of serum-free medium conditioned by T lymphocytes stimulated with phytohemagglutinin (PHA-LCM) was also added. CFU-GM were assayed in medium containing 20% heat-inactivated human AB serum, 10% PHA-LCM, and 2 x l0 cells/mL.
CFU-Mk
were plated at a concentration of 2 x l05/mL in medium containing 30% human citrated AB plasma and 5% PHA-LCM. 
BFU-Et
Pre Post
CFU-GM
Pre Post 89±7  126±11  63±3  99±4   2  162±13  933±45  24±3  81±4  59±4  240±25  68±8  170±10  25±2  44±4   3  399±38  1,903±82  89±7  319±15  186±11  428±19  142±9  260±16  110±10  261±17   4  705±52  1,620±40  57±4  115±14  83±5  194±21  114±13  158±13  63±4  107±8   5  475±2  1,723±111  99±6  190±10  202±10  362±20  105±10  186±12  39±2  85±7   6  713±42  1,958±126  64±5  280±19  136±12  399±32  122±7  235±17  105±5  187±  11   7  158±12  993±31  59±6  292±16  178±9  366±21  176±12  286±22  59±4  97±8   8 
CFU-Mk

